When the Face Changes Faster Than the Skin

Exploring the biology of facial change following rapid weight loss.

The face is not made of skin alone.

Beneath the surface sits a complex architecture of connective tissue, extracellular matrix and subcutaneous fat. Together, these structures give the face its volume, tension and shape.

When significant weight loss happens quickly, that architecture can change just as quickly.

The growing use of GLP-1 therapies has brought new attention to a phenomenon commonly described as “Ozempic face”: the hollowing, loss of facial volume and increased appearance of skin laxity that can accompany rapid weight reduction.

The issue is not simply dryness or a change at the surface of the skin. Loss of subcutaneous facial fat can alter the structural support beneath it, leaving the skin to adapt to a considerably different foundation.

For SEIJI, this raises a different question:

What if skincare could address not only the surface of the skin, but some of the biological processes involved in the tissue beneath it?

Looking Below the Surface

Our research into S-001 began with its activity in inflammation-stressed adipose tissue.

In laboratory testing, S-001 demonstrated activity across several biological processes relevant to tissue structure and remodeling.

It was observed to support lipid accumulation and adipogenic function under inflammatory conditions, alongside effects on cellular proliferation. The active also showed changes in inflammatory signaling, including IL-6 and MCP-1.

At the level of the extracellular matrix, testing showed restoration of fibronectin expression toward baseline and an increase in procollagen type I.

These findings are particularly interesting because facial volume and skin firmness do not exist independently.

Adipose tissue provides physical volume. The extracellular matrix provides structure. Collagen contributes strength. Fibronectin participates in the organization and attachment of tissue. Inflammatory signaling can influence all of them.

Rather than approaching each process independently, S-001 is being investigated for the way it may interact with several of these systems at once.

From Volume Loss to Tissue Remodeling

Traditional skincare has largely concentrated on the epidermis and dermis.

Rapid facial volume loss presents a different problem.

When the tissue beneath the skin changes, the visible result may include hollowing around the cheeks and temples, deeper folds and a reduction in the support that previously gave the face its shape.

This has led us to explore a broader idea of skin longevity: structural remodeling rather than surface correction alone.

The early laboratory profile of S-001 suggests several areas worthy of further investigation:

• Adipose tissue function

• Inflammatory signaling

• Extracellular matrix organization

• Collagen production

• Tissue remodeling following structural stress

Together, they form the basis of a research direction we describe internally as cellular cushion restoration.

Not adding artificial volume.

Not disguising structural change.

But understanding whether the biological environment responsible for maintaining healthy tissue can itself be supported.

A New Question for Skincare

The rapid growth of GLP-1 therapies is changing more than weight management.

It is creating new questions for dermatology, aesthetic medicine and cosmetic science.

What happens to facial tissue after substantial weight loss?

How does adipose tissue recover?

How does the extracellular matrix respond?

And can topical biotechnology eventually play a role in supporting that transition?

These are questions we believe deserve considerably more research.

S-001 remains in early development. The results discussed here are laboratory findings and do not yet demonstrate that the ingredient can restore facial volume, tighten skin or treat post-weight-loss facial changes in people. Toxicology, formulation work and further testing are required before those conclusions can be made.

For us, that distinction matters.

SEIJI is interested in what the science may become, but equally in being precise about what the science can demonstrate today.

This is the beginning of that investigation.

SEIJI
Vancouver, Canada

Research notes from the development of S-001.